Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/13341
Title: Angiotensin converting enzyme inhibitors in perspective: an update.
Authors: Burrell, Louise M;Johnston, Colin I
Affiliation: Department of Medicine, Austin Hospital, Melbourne, Victoria.
Issue Date: 1-Jul-1993
Citation: Australian Family Physician; 22(7): 1243-7, 1251, 1255
Abstract: Orally active inhibitors of angiotensin converting enzyme (ACE) have made a major impact on the clinical therapy of hypertension, congestive cardiac failure and ventricular remodelling after myocardial infarction. The ACE inhibitors combine the advantages of efficacy and low incidence of side effects, with the promise of cardio-, vasculo- and reno- protection.
Internal ID Number: 8373316
URI: http://ahro.austin.org.au/austinjspui/handle/1/13341
URL: http://www.ncbi.nlm.nih.gov/pubmed/8373316
Type: Journal Article
Subjects: Age Factors
Angiotensin-Converting Enzyme Inhibitors.pharmacology.therapeutic use
Diabetic Nephropathies.drug therapy
Drug Therapy, Combination
Heart Diseases.drug therapy
Hemodynamics.drug effects
Humans
Hypertension.drug therapy
Hypertension, Renal.drug therapy
Hypertension, Renovascular.drug therapy
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.